Follicle Stimulating Hormone Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Publication Month: Nov 2020 | No. of Pages: 100 Published By: 99Strategy
Single User License: US $ 2800
Corporate User License: US $ 5600

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Follicle Stimulating Hormone market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Follicle Stimulating Hormone market segmented into
Infertility Treatment
Urinary FSH

Based on the end-use, the global Follicle Stimulating Hormone market classified into
Infertility Treatment
Assisted Reproductive Technology

Based on geography, the global Follicle Stimulating Hormone market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL FOLLICLE STIMULATING HORMONE INDUSTRY
2.1 Summary about Follicle Stimulating Hormone Industry
2.2 Follicle Stimulating Hormone Market Trends
2.2.1 Follicle Stimulating Hormone Production & Consumption Trends
2.2.2 Follicle Stimulating Hormone Demand Structure Trends
2.3 Follicle Stimulating Hormone Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Recombinant FSH
4.2.2 Urinary FSH
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Infertility Treatment
4.3.2 Assisted Reproductive Technology
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Recombinant FSH
5.2.2 Urinary FSH
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Infertility Treatment
5.3.2 Assisted Reproductive Technology
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Recombinant FSH
6.2.2 Urinary FSH
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Infertility Treatment
6.3.2 Assisted Reproductive Technology
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Recombinant FSH
7.2.2 Urinary FSH
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Infertility Treatment
7.3.2 Assisted Reproductive Technology
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Recombinant FSH
8.2.2 Urinary FSH
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Infertility Treatment
8.3.2 Assisted Reproductive Technology
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Recombinant FSH
9.2.2 Urinary FSH
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Infertility Treatment
9.3.2 Assisted Reproductive Technology
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merck Serono
10.1.2 MSD
10.1.3 IBSA
10.1.4 Ferring
10.1.5 Livzon
10.1.6 Techwell
10.1.7 GenSci
10.2 Follicle Stimulating Hormone Sales Date of Major Players (2017-2020e)
10.2.1 Merck Serono
10.2.2 MSD
10.2.3 IBSA
10.2.4 Ferring
10.2.5 Livzon
10.2.6 Techwell
10.2.7 GenSci
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

Tables and Figures

List of Table
1.Table Follicle Stimulating Hormone Product Type Overview
2.Table Follicle Stimulating Hormone Product Type Market Share List
3.Table Follicle Stimulating Hormone Product Type of Major Players
4.Table Brief Introduction of Merck Serono
5.Table Brief Introduction of MSD
6.Table Brief Introduction of IBSA
7.Table Brief Introduction of Ferring
8.Table Brief Introduction of Livzon
9.Table Brief Introduction of Techwell
10.Table Brief Introduction of GenSci
11.Table Products & Services of Merck Serono
12.Table Products & Services of MSD
13.Table Products & Services of IBSA
14.Table Products & Services of Ferring
15.Table Products & Services of Livzon
16.Table Products & Services of Techwell
17.Table Products & Services of GenSci
18.Table Market Distribution of Major Players
19.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
20.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
21.Table Global Follicle Stimulating Hormone Market Forecast (Million USD) by Region 2021f-2026f
22.Table Global Follicle Stimulating Hormone Market Forecast (Million USD) Share by Region 2021f-2026f
23.Table Global Follicle Stimulating Hormone Market Forecast (Million USD) by Demand 2021f-2026f
24.Table Global Follicle Stimulating Hormone Market Forecast (Million USD) Share by Demand 2021f-2026f



List Of Figures
List of Figure
1.Figure Global Follicle Stimulating Hormone Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Follicle Stimulating Hormone Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Follicle Stimulating Hormone Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Follicle Stimulating Hormone Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Follicle Stimulating Hormone Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Follicle Stimulating Hormone Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Follicle Stimulating Hormone Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Recombinant FSH Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Urinary FSH Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Infertility Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Assisted Reproductive Technology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Recombinant FSH Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Urinary FSH Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Infertility Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Assisted Reproductive Technology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Recombinant FSH Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Urinary FSH Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Infertility Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Assisted Reproductive Technology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Recombinant FSH Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Urinary FSH Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Infertility Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Assisted Reproductive Technology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Recombinant FSH Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Urinary FSH Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Infertility Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Assisted Reproductive Technology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Recombinant FSH Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Urinary FSH Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Infertility Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Assisted Reproductive Technology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Follicle Stimulating Hormone Sales Revenue (Million USD) of Merck Serono 2017-2020e
60.Figure Follicle Stimulating Hormone Sales Revenue (Million USD) of MSD 2017-2020e
61.Figure Follicle Stimulating Hormone Sales Revenue (Million USD) of IBSA 2017-2020e
62.Figure Follicle Stimulating Hormone Sales Revenue (Million USD) of Ferring 2017-2020e
63.Figure Follicle Stimulating Hormone Sales Revenue (Million USD) of Livzon 2017-2020e
64.Figure Follicle Stimulating Hormone Sales Revenue (Million USD) of Techwell 2017-2020e
65.Figure Follicle Stimulating Hormone Sales Revenue (Million USD) of GenSci 2017-2020e
66.

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets